Reproductive technologies: patenting processes, not people
11 September 2018
|
Ellie Mertens, New York
How can reproductive technologies be protected when they relate to natural processes? Is a human gamete or embryo a “human organism” in terms of patent law? Ellie Mertens analyses the situation in the US and other jurisdictions
An eight-cell embryo ready for transfer three days after fertilisationFrom clones to chimeras, reproductive technologies are developing faster than laws that would protect or regulate them. However, there are some guidelines to work from.Jason Jardine, partner at Knobbe Martens in...
Please
log in to read the rest of this article.
New to Managing Intellectual Property? Take advantage of free access to up to 5 articles on Managing IP and become a member today. It’s free to join and the benefits start straight away.
Already registered?
Please make sure you log in to read the rest of the article.
Log in
Join us now
Gain FREE access to up to five free articles when you register now. Join here